Waters Corp (WAT) Financial Statements
Historical financial data — 40 statements covering FY2016–FY2025
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures...
Waters Corp's revenue increased 7.0% year over year, from $2.96B to $3.17B.
Net income increased 0.8% over the same period, from $637.8M to $642.6M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 46% in total.
Total debt decreased by 41.7% to $947.4M.
The debt-to-equity ratio stands at 0.37, indicating a moderate leverage profile.
Operating cash flow declined 14.4% to $652.6M.
Waters Corp maintains a strong net profit margin of 20.3%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $2.14B+49.9% | $426.0M | $1.26B | $553.5M | $372.7M | $4.50B | $2.46B | $905.5M |
| Q1 FY2024 | $636.8M-70.2% | $102.2M | $375.1M | $133.8M | $262.9M | $4.51B | $2.01B | $1.26B |
| Q2 FY2024 | $708.5M+11.3% | $142.7M | $420.3M | $189.1M | N/A | $4.45B | $2.01B | $1.41B |
| Q3 FY2024 | $2.09B+194.4% | $406.4M | $1.23B | $534.1M | $522.0M | $4.51B | $1.83B | $1.60B |
| Q1 FY2025 | $661.7M-68.3% | $121.4M | $385.0M | $151.7M | $259.6M | $4.59B | $1.36B | $1.96B |
| Q2 FY2025 | $1.43B+116.6% | $268.5M | $834.9M | $340.0M | $300.7M | $4.72B | $1.20B | $2.16B |
| Q3 FY2025 | $2.23B+55.8% | $417.4M | $1.31B | $532.1M | $488.0M | $4.86B | $947.2M | $2.33B |
| Q1 FY2026 | $1.27B-43.3% | $-72.0M | $588.0M | $-47.0M | $-3.0M | $24.53B | $4.86B | $15.29B |
Balance Sheet Summary (Latest Period)
Total Assets
$5.08B
Total Liabilities
$2.52B
Total Equity
$2.56B
Cash & Equivalents
$587.8M
Total Debt
$947.4M
Current Assets
$2.15B
Current Liabilities
$1.24B
Retained Earnings
$10.43B